We first determined effects of CRISPR-Cas9-mediated knockout (KO) of LSD1 on the CoREST complex and on GFI1 and its targets in AML OCI-AML5 and post-MPN sAML SET-2 cells. This evidence concerns the gene PRSS27 and acute myeloid leukemia.